Lycopene inhibits proliferation, invasion and migration of human breast cancer cells

Biomolecules and Therapeutics

Volumn 18, Issue 1, 2010, Pages 92-98

  Koh, Min Soo ^a   Hwang, Jin Sun ^a   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Breast cancer; H Ras MCF10A; Invasion; Lycopene; MDA MB 231

Indexed keywords

LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 10A; CELL STRAIN MDA MB 231; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LABELING INDEX; METASTASIS; METASTASIS INHIBITION;

LYCOPERSICON ESCULENTUM;

EID: 76749110708     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2010.18.1.092     Document Type: Article

References (39)

1. Agarwal, S. and Rao, V. A. (2000). Tomato lycopene and its role in human health and chronic diseases. CMJA. 163, 739-744.
2. Arab, L. and Steck, S. (2000). Lycopene and cardiovascular disease. Am. J. Clin. Nutr. 71 Suppl, 1691S-1695S.
3. Boileau, A. C., Merchen, N. R., Wasson, K., Atkinson, C. A. and Erdman, J. W. (1999). Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J. Nutr. 129, 1176-1181.
4. Chan, C. M., Fang, J. Y., Lin, H. H., Yang, C. Y. and Hung, C. F. (2009). Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways. Biochem. Biophys. Res. Commun. 388, 172-176.
5. Chiang, H. S., Wu, W. B., Fang, J. Y., Chen, D. F., Chen, B. H., Huang, C. C., Chen, Y. T. and Hung, C. F. (2007). Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sci. 81, 1509-1517.
6. Clair, T., Miller, W. and Cho-Chung, Y. (1987). Prognostic significance of the expression of the ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res. 49, 5290-5293.
7. Cunningham, F. X. Jr., Sun, Z., Chamovitz, D., Hirschberg, J. and Gantt, E. (1994). Molecular structure and enzymatic function of lycopene cyclase from the Cyanobacterium Synechococcus sp Strain PCC7942. Plant. Cell 6, 1107-1121.
8. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E. and Taylor, S. M. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52, 701-708.
9. Ferguson, L. R. (1994). Antimutagens as cancer chemopreventive agents in the diet. Mut. Res. 307, 395-410.
10. Franceschi, S., Bidoli, E., LaVeccia, C., Talamini, R., D'Avanzo, B. and Negri, E. (1994). Tomatoes and risk of digestive tract cancers. Int. J. Cancer 59, 181-184.
11. Freemantle, S. J., Spinella, M. J. and Dmitrovsky, E. (2003). Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305-7315.
12. Giovannucci, E. (1999). Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst. 91, 317-331.
13. Huang, C. S., Fan, Y. E., Lin, C. Y. and Hu, M. L. (2007). Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 18, 449-456.
14. Huang, C. S., Liao, J. W. and Hu, M. L. (2008). Lycopene inhibits experimental metastasis of human hepatoma SKHep-1 cells in athymic nude mice. J. Nutr. 138, 538-543.
15. Hwang, E. S. and Bowen, P. E. (2004). Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J. Med. Food 7, 284-289.
16. Hwang, E. S. and Lee, H. J. (2006). Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp. Biol. Med. 231, 322-327.
17. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M. J. (2007). Cancer Statistics. CA Cancer J. Clin. 57, 43-66.
18. Kim, E. S., Jeong, J. B., Kim, S., Lee, K. M., Ko, E., Noh, D. Y., Hwang, K. T., Ha, J. H., Lee, C. H., Kim, S. G. and Moon, A. (2010). The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Res. Treat. [Epub ahead of print].
19. Kim, I. Y. and Moon, A. (2004). Inhibition of invasive phenotype and induction of apoptosis in human breast cancer cells by chemopreventive agents. J. Korean Assoc. Cancer Prev. 9, 59-67.
20. Kim, L., Rao, A. V. and Rao, L. G. (2002). Effect of lycopene on prostate LNCaP cancer cells in culture. J. Med. Food 5, 181-187.
21. Kim, M. S., Lee, E. J., Kim, H. R. and Moon, A. (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63, 5454-5461.
22. Levy, J., Bosin, E., Feldman, B., Giat, Y., Miinster, A., Danilenko, M. and Sharoni, Y. (1995). Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer 24, 257-266.
23. Liotta, L. A., Abe, S., Robey, P. G. and Martin, G. R. (1979). Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. U.S.A. 76, 2268-2272.
24. Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Kim, H. R. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer 85, 176-181.
25. Nagasawa, H., Mitamura, T., Sakamoto, S. and Yamamoto, K. (1995). Effects of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res. 15, 1173-1178.
26. Omoni, O. A. and Aluko, E. R. (2005). The anti-carcinogenic and anti-atherogenic effects of lycopene: a review. Trends Food Sci. Technol. 16, 344-350.
27. Prakash, P., Russell, R. M. and Krinsky, N. I. (2001). In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J. Nutr. 131, 1574-1580.
28. Rao, A. V. and Agarwal, S. (1999). Role of lycopene as anti-oxidant carotenoid in the prevention of chronic diseases: a review. Nut. Res. 19, 305-323.
29. Rao, A. V. and Agarwal, S. (2000). Role of anti-oxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr. 19, 563-569.
30. Salman, H., Bergman, M., Djaldetti, M. and Bessler, H. (2007). Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother. 61, 366-369.
31. Shi, J. (2000). Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit. Rev. Food Sci. Nutr. 40, 1-42.
32. Shin, I., Kim, S., Song, H., Kim, H. R. and Moon, A. (2005). H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 280, 14675-14683.
33. Song, H., Ki, S. H., Kim, S. G. and Moon, A. (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496.
34. Stahl, W. and Sies, H. (1996). Lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys. 336, 1-9.
35. Stavric, B. (1994). Role of chemopreventers in human diet. Clinical Biochem. 27, 319-332.
36. Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-557.
37. Weisburger, J. H. (2002). Lycopene and tomato products in health promotion. Exp. Biol. Med. 227, 924-927.
38. Wu, K., Schwatz, S. J., Platz, E. A., Clinton, S. K., Erdman, J. W., Ferruzzi, M. G., Willett W. C. and Giovannucci E. L. (2003). Variations in plasma lycopene and specific isomers over time in a cohort of US men. J. Nutr. 133, 1930-1936.
39. Yang, E. and Korsmeyer, S. J. (1996). Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88, 386-401.